RecallCheckr

Teva Pharmaceuticals USA, Inc recalls

13 recalls on record · FDA

Every recall we have on record for Teva Pharmaceuticals USA, Inc, compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.

Filter:
Health Serious

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4…

CGMP Deviations: use of an unapproved raw material

Teva Pharmaceuticals USA, Inc Apr 15, 2026
Read the recall
Health Serious

Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4…

CGMP Deviations: use of an unapproved raw material

Teva Pharmaceuticals USA, Inc Apr 15, 2026
Read the recall
Health Serious

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg,…

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Teva Pharmaceuticals USA, Inc Apr 1, 2026
Read the recall
Health Serious

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg,…

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Teva Pharmaceuticals USA, Inc Apr 1, 2026
Read the recall
Health Serious

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL,…

Subpotent drug; Clavulanate Potassium component

Teva Pharmaceuticals USA, Inc Nov 12, 2025
Read the recall
Health Serious

Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS…

CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

Teva Pharmaceuticals USA, Inc Nov 5, 2025
Read the recall
Health Serious

Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS…

CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

Teva Pharmaceuticals USA, Inc Nov 5, 2025
Read the recall
Health Serious

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by…

Presence of foreign tablets/capsules.

Teva Pharmaceuticals USA, Inc Jul 2, 2025
Read the recall
Health Serious

Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged…

Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit

Teva Pharmaceuticals USA, Inc Feb 12, 2025
Read the recall
Health Serious

Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva…

Superpotent Drug

Teva Pharmaceuticals USA, Inc Aug 28, 2024
Read the recall
Health Serious

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, …

Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Teva Pharmaceuticals USA, Inc Apr 17, 2024
Read the recall
Health Moderate

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons,…

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Teva Pharmaceuticals USA, Inc Feb 21, 2024
Read the recall
Health Serious

Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by:…

Failed Dissolution Specifications

Teva Pharmaceuticals USA, Inc Feb 7, 2024
Read the recall